IDH1 and IDH2 are frequently mutated in cancer, and the IDH1/2-mutant (IDHm) enzymes acquire a neomorphic activity that results in the conversion of αKG to d-2-HG (Dang et al. 2009, Ward et al. 2010). Here, IDH2 is linked to cancer.